US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 28.990
  • +2.810+10.73%
Close Nov 19 16:00 ET
  • 29.160
  • +0.170+0.59%
Post 16:46 ET
3.61BMarket Cap-14280P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
SYFOVRE151.96M77.20%
EMPAVELI24.61M12.50%
Licensing and other revenue20.26M10.29%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday-2.87%